Published in Infect Immun on February 01, 1984
Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum. J Exp Med (1986) 2.40
Characterization of antibody-reactive epitopes on the 65-kilodalton protein of Mycobacterium leprae. Infect Immun (1987) 2.30
Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection. J Clin Invest (1989) 1.98
Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. J Clin Invest (1985) 1.35
Molecular basis for serum resistance in Neisseria gonorrhoeae. Clin Microbiol Rev (1989) 1.32
Antigenic and immunogenic properties of cyanogen bromide peptides from gonococcal outer membrane protein IB. Evidence for the existence of a surface-exposed conserved epitope. J Exp Med (1987) 1.10
Role of anti-pilus antibodies in host defense against gonococcal infection studied with monoclonal anti-pilus antibodies. Infect Immun (1985) 1.06
Human immunoglobulin G antibody response to the major gonococcal iron-regulated protein. Infect Immun (1987) 1.05
Specificity of antibodies against Neisseria gonorrhoeae that stimulate neutrophil chemotaxis. Role of antibodies directed against lipooligosaccharides. J Clin Invest (1987) 1.00
The specificity of serum and local antibodies in female gonorrhoea. Clin Exp Immunol (1986) 0.86
Humoral immune response to gonococcal infections. Clin Microbiol Rev (1989) 0.86
Emergence of bactericidal and opsonizing antibody to Vibrio vulnificus following bacterial infection. J Clin Microbiol (1986) 0.79
Serovar specific immunity to Neisseria gonorrhoeae: does it exist? Genitourin Med (1995) 0.77
Gonorrhea - an evolving disease of the new millennium. Microb Cell (2016) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Disseminated gonococcal infections caused by Neisseria gonorrhoeae with unique nutritional requirements. J Infect Dis (1975) 7.92
Disseminated gonococcal infection. Ann Intern Med (1971) 5.66
Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera. J Clin Invest (1976) 5.54
Quantitative determination of antibody to gonococcal pili. Changes in antibody levels with gonococcal infection. J Clin Invest (1973) 4.90
Neisseria gonorrhoeae acquire a new principal outer-membrane protein when transformed to resistance to serum bactericidal activity. Infect Immun (1978) 4.03
Low antibiotic resistance of gonococci causing disseminated infection. N Engl J Med (1973) 3.48
Antigen-specific serotyping of Neisseria gonorrhoeae: characterization based upon principal outer membrane protein. Infect Immun (1981) 3.08
Characterization of gonococcal antigens responsible for induction of bactericidal antibody in disseminated infection. J Clin Invest (1977) 2.46
Serology of Neisseria gonorrhoeae: W-antigen serogrouping by coagglutination and protein I serotyping by enzyme-linked immunosorbent assay both detect protein I antigens. Infect Immun (1982) 1.82
Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment. J Clin Invest (1981) 1.62
Clinical manifestations of disseminated infection caused by Neisseria gonorrhoeae are linked to differences in bactericidal reactivity of infecting strains. Ann Intern Med (1981) 1.31
Antigenic specificity of antibodies in vaginal secretions during infection with Neisseria gonorrhoeae. J Infect Dis (1980) 1.20
Immunoglobulin class responsible for gonococcal bactericidal activity of normal human sera. J Immunol (1979) 1.18
Gonococcal pili: safety and immunogenicity in humans and antibody function in vitro. J Infect Dis (1982) 1.01
Condom use to prevent incident STDs: the validity of self-reported condom use. Sex Transm Dis (1995) 5.94
Serological classification of Neisseria gonorrhoeae with monoclonal antibodies. Infect Immun (1982) 5.54
Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera. J Clin Invest (1976) 5.54
Production and partial characterization of monoclonal antibodies to Mycobacterium leprae. Infect Immun (1982) 5.13
Studies on the bacteremia of bacterial endocarditis. JAMA (1967) 5.00
Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med (1975) 4.99
Neisseria pili proteins: amino-terminal amino acid sequences and identification of an unusual amino acid. Biochemistry (1978) 4.95
Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital-Cornell Medical Center. Arch Intern Med (1970) 4.93
Quantitative determination of antibody to gonococcal pili. Changes in antibody levels with gonococcal infection. J Clin Invest (1973) 4.90
Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med (1988) 4.81
The physician's responsibility toward hopelessly ill patients. A second look. N Engl J Med (1989) 4.20
Parental monitoring: association with adolescents' risk behaviors. Pediatrics (2001) 4.15
Pili as a mediator of the attachment of gonococci to human erythrocytes. Infect Immun (1976) 4.11
Neisseria gonorrhoeae acquire a new principal outer-membrane protein when transformed to resistance to serum bactericidal activity. Infect Immun (1978) 4.03
Antigenic heterogeneity of gonococcal pili. J Exp Med (1975) 3.99
Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med (1988) 3.71
Differential attachment by piliated and nonpiliated Neisseria gonorrhoeae to human sperm. Infect Immun (1974) 3.51
Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol (2003) 3.50
Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic. J Clin Microbiol (1995) 3.47
National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA (1990) 3.25
Studies on gonococcus infection. 3. Correlation of gonococcal colony morphology with infectivity for the chick embryo. J Exp Med (1973) 3.22
Tissue microarray: a new technology for amplification of tissue resources. Cancer J (2001) 3.19
Etiology of nongonococcal urethritis. Evidence for Chlamydia trachomatis and Ureaplasma urealyticum. J Clin Invest (1977) 3.18
Antigen-specific serotyping of Neisseria gonorrhoeae: characterization based upon principal outer membrane protein. Infect Immun (1981) 3.08
Immunochemical characterization of a protein associated with Mycobacterium leprae cell wall. Infect Immun (1985) 2.88
Nonculture tests for genital tract chlamydial infection. What does the package insert mean, and will it mean the same thing tomorrow? Sex Transm Dis (1992) 2.80
Partner type and condom use. AIDS (2000) 2.78
A mammalian homologue of GCN2 protein kinase important for translational control by phosphorylation of eukaryotic initiation factor-2alpha. Genetics (2000) 2.73
Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA (1995) 2.71
Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs. J Clin Microbiol (1995) 2.62
The rapid test paradox: when fewer cases detected lead to more cases treated: a decision analysis of tests for Chlamydia trachomatis. Sex Transm Dis (1999) 2.52
Attachment role of gonococcal pili. Optimum conditions and quantitation of adherence of isolated pili to human cells in vitro. J Clin Invest (1978) 2.50
Neisseria gonorrhoeae: effects of systemic immunization on resistance of chimpanzees to urethral infection. J Infect Dis (1974) 2.48
Monoclonal antibodies to a 28,000 mol. wt protein antigen of Mycobacterium leprae. Clin Exp Immunol (1985) 2.36
Ultrastructural localization of specific gonococcal macromolecules with antibody-gold sphere immunological probes. Infect Immun (1984) 2.31
Characterization of antibody-reactive epitopes on the 65-kilodalton protein of Mycobacterium leprae. Infect Immun (1987) 2.30
A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group. N Engl J Med (1991) 2.30
Antigens of Treponema pallidum recognized by IgG and IgM antibodies during syphilis in humans. J Infect Dis (1985) 2.29
Epidemiology of gonorrhea: distribution and temporal changes in auxotype/serovar classes of Neisseria gonorrhoeae. Sex Transm Dis (1987) 2.27
Leukocyte bactericidal activity in chronic granulomatous disease: correlation of bacterial hydrogen peroxide production and susceptibility to intracellular killing. J Bacteriol (1969) 2.25
Amine content of vaginal fluid from untreated and treated patients with nonspecific vaginitis. J Clin Invest (1979) 2.25
Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA (1983) 2.25
Leukocyte function in chronic granulomatous disease of childhood. Studies on a seventeen year old boy. Am J Med (1969) 2.23
Gonococcal infections. Ann Intern Med (1985) 2.23
Brucellosis in the United States, 1960-1972. An abattoir-associated disease. Part I. Clinical features and therapy. Medicine (Baltimore) (1974) 2.23
Serology of Neisseria gonorrhoeae: coagglutination serogroups WI and WII/III correspond to different outer membrane protein I molecules. Infect Immun (1982) 2.21
Fluorescent monoclonal antibody for confirmation of Neisseria gonorrhoeae cultures. J Clin Microbiol (1987) 2.21
Generation and characterization of monoclonal antibodies to the phenolic glycolipid of Mycobacterium leprae. Infect Immun (1984) 2.20
A serological test for leprosy with a glycolipid specific for Mycobacterium leprae. Science (1983) 2.18
Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature. Rev Infect Dis (1983) 2.08
Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA (1996) 2.07
Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol (2000) 2.02
Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance. Sex Transm Dis (1999) 1.99
Gonorrhea in the HIV era: a reversal in trends among men who have sex with men. Am J Public Health (2001) 1.94
The effect of an NADH oxidase inhibitor (hydrocortisone) on polymorphonuclear leukocyte bactericidal activity. J Clin Invest (1970) 1.91
Mechanical failure of the latex condom in a cohort of women at high STD risk. Sex Transm Dis (1999) 1.90
Role of the vegetation in experimental Streptococcus viridans endocarditis. Infect Immun (1974) 1.89
Confirming positive results of nucleic acid amplification tests (NAATs) for Chlamydia trachomatis: all NAATs are not created equal. J Clin Microbiol (2005) 1.88
Effectiveness of an intervention promoting the female condom to patients at sexually transmitted disease clinics. Am J Public Health (2000) 1.80
Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis (1994) 1.78
Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to the fluoroquinolones. J Infect Dis (1997) 1.75
Antimicrobial therapy of experimental enterococcal endocarditis. Antimicrob Agents Chemother (1975) 1.75
Most Mycobacterium leprae carbohydrate-reactive monoclonal antibodies are directed to lipoarabinomannan. Infect Immun (1987) 1.73
Patients attending STD clinics in an evolving health care environment. Demographics, insurance coverage, preferences for STD services, and STD morbidity. Sex Transm Dis (1997) 1.69
Brucellosis in the United States, 1960-1972. An abattoir-associated disease. Part II. Diagnostic aspects. Medicine (Baltimore) (1974) 1.69
Antigen-specific serotyping of Neisseria gonorrhoeae. I. Use of an enzyme-linked immunosorbent assay to quantitate pilus antigens on gonococci. J Infect Dis (1978) 1.69
Prevalence and persistence of Neisseria cinerea and other Neisseria spp. in adults. J Clin Microbiol (1988) 1.67
Characterization of patients accepting and refusing routine, voluntary HIV antibody testing in public sexually transmitted disease clinics. Sex Transm Dis (1994) 1.63
Evaluation of Syva enzyme immunoassay for detection of Chlamydia trachomatis in genital specimens. J Clin Microbiol (1990) 1.59
Amplification of tissue by construction of tissue microarrays. Exp Mol Pathol (2001) 1.57
Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med (1986) 1.57
Gonococcal salpingitis is less likely to recur with Neisseria gonorrhoeae of the same principal outer membrane protein antigenic type. Am J Obstet Gynecol (1980) 1.56
The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics. Arch Intern Med (1990) 1.55
Sustained bacteremia in patients with prosthetic cardiac valves. N Engl J Med (1972) 1.54
Effect of HIV posttest counseling on STD incidence. JAMA (1992) 1.53
Comparison of bile and trypticase soy broth for isolation Salmonella from blood. Am J Clin Pathol (1966) 1.52
Gene typing of Chlamydia trachomatis by polymerase chain reaction and restriction endonuclease digestion. Sex Transm Dis (1993) 1.52
Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex Transm Dis (1997) 1.51
Exact definition of species-specific and cross-reactive epitopes of the 65-kilodalton protein of Mycobacterium leprae using synthetic peptides. J Immunol (1988) 1.51
Transmission of Chlamydia trachomatis among sex partners assessed by polymerase chain reaction. J Infect Dis (1993) 1.49
Confirmation of association of protein I serotype of Neisseria gonorrhoeae with ability to cause disseminated infection. Infect Immun (1983) 1.48
Compliance with doxycycline therapy in sexually transmitted diseases clinics. Sex Transm Dis (1998) 1.47
Modification of syphilitic genital ulcer manifestations by coexistent HIV infection. Sex Transm Dis (2001) 1.47
Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection. J Infect Dis (1992) 1.46
Ceftriaxone therapy for asymptomatic neurosyphilis. Case report and Western blot analysis of serum and cerebrospinal fluid IgG response to therapy. Sex Transm Dis (1986) 1.46
Influence of Plasmodium berghei infection on susceptibility to salmonella infection. Proc Soc Exp Biol Med (1965) 1.46
Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: effects of concomitant infections. J Infect Dis (1998) 1.45
Alcohol and other substance use in STD clinic patients: relationships with STDs and prevalent HIV infection. Sex Transm Dis (1994) 1.45
2-mercaptoethanol Brucella agglutination test: usefulness for predicting recovery from brucellosis. J Clin Microbiol (1980) 1.44
Synergism of vancomycin and streptomycin for enterococci. Am J Med Sci (1970) 1.44
Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs. J Clin Microbiol (2005) 1.43
Validity of self-reported sexually transmitted diseases among African American female adolescents participating in an HIV/STD prevention intervention trial. Sex Transm Dis (2001) 1.43
Factors influencing host resistance to Salmonella infections: the effects of hemolysis and erythrophagocytosis. Am J Med Sci (1967) 1.42
A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide. Science (1988) 1.42
Interpartner reliability of reporting of recent sexual behaviors. Am J Epidemiol (1991) 1.41
Multicenter randomized study of single-dose ofloxacin versus amoxicillin-probenecid for treatment of uncomplicated gonococcal infection. Antimicrob Agents Chemother (1989) 1.41
Congenital malaria: a report of four cases and a review. J Pediatr (1982) 1.40
Protection against infection with Neisseria gonorrhoeae by immunization with outer membrane protein complex and purified pili. J Infect Dis (1977) 1.38